Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: RWReeves who wrote (399)	2/17/2000 11:27:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 743

rants, hopes, and fears... biz.yahoo.com ''We have largely refocused the company in the anti-angiogenesis area and the respiratory area since the negative regulatory decision for LOCILEX(TM) in July 1999,'' Mr. Dougherty continued. ''However, LOCILEX(TM) is an asset which continues to have value, and we hope to reassess the further development of LOCILEX(TM) in 2000.'' I was somewhat disappointed with that tepid wording a few days ago, and used today's spike to take myself out of the rest of my shares in Magainin. MAGN has been a sentimental pick, I've done well juggling it, and I hope to trade it from time to time, and perhaps repurchase it if they turn up the volume on Pex--but I think that they could give us more to chew on. RANT. Largely refocused is great--and I'm sure the fellas who got those shares below a buck in the placement feel pretty good about now too, but I think this one needs a little re-evaluation at $6 after a day when it moved up 42% on news that was not news. fwiw...I spent the money on Gliatech. HOPES. FEARS, none at present...trend is friend.